14 ADHD Clinical Trials in Dallas, PA (2026)

Q: How do I join a clinical trial in Dallas?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you.

Recruiting ADHD Studies in Dallas

NCT03193970Recruiting

Measuring Surgical Recovery After Radical Cystectomy

The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of th...

Dallas, PA2,000 participantsM.D. Anderson Cancer Center

View Study Details

NCT05646485Recruiting

Bladder Cancer Screening Trial

There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help asses...

Dallas, PA1,000 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT03193541Recruiting

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic h...

Dallas, PA900 participantsCedars-Sinai Medical Center

View Study Details

NCT05825950Recruiting

Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

This is a multi-center study and the aim is to develop and validate an Artificial Intelligence (AI) -based histologic analysis tool to predict responsiveness to intravesical Bacillus Calmette-Guérin (...

Dallas, PA600 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06797245Recruiting

APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women

The APPROVE trial is a multi-centered, randomized controlled trial designed to assess differences in symptom improvement, quality of life, bladder symptoms, satisfaction with treatment and continued t...

Dallas, PA596 participantsMedstar Health Research Institute

View Study Details

NCT05080998Recruiting

Longitudinal Bladder Cancer Study for Tumour Recurrence

Surveillance for recurrence of urothelial carcinoma (UC) requires frequent cystoscopy, which is invasive, expensive and time-consuming. An accurate urinary biomarker has the potential to reduce the nu...

Dallas, PA450 participantsPacific Edge Limited

View Study Details

NCT04564781Recruiting

Predicting BCG Response

To date, there are no diagnostics capable of predicting treatment response to intravesical BCG. Because of this severe limitation, nearly 50% of patients treated with BCG fail therapy and will a) requ...

Dallas, PA400 participantsCedars-Sinai Medical Center

View Study Details

NCT03193515Recruiting

A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer

Voided urinary cytology (VUC) is the most widely used urine-based assay for detecting bladder cancer (BCa); however, it fails to detect approximately 50% of low-grade or early stage BCa when it is mos...

Dallas, PA300 participantsCedars-Sinai Medical Center

View Study Details

NCT05796375Recruiting

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

The purpose of this research is to determine whether bladder cancer monitoring can be improved by replacing some cystoscopy procedures with urine testing. Specifically, this study examines whether the...

Dallas, PA240 participantsWhite River Junction Veterans Affairs Medical Center

View Study Details

NCT06496750Recruiting

Ketamine for Methamphetamine Use Disorder

This study aims to determine whether treatment response with IV ketamine is superior to treatment response with IV midazolam in adults with moderate to severe MUD. The study design is a 12-week rando...

Dallas, PA120 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT05483868Recruiting

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

The main objectives of this study are to determine the feasibility and safety of Belzupacap Sarotalocan (AU-011, bel-sar) treatment of bladder cancer utilizing focal injections with or without laser a...

Dallas, PA55 participantsAura Biosciences

View Study Details

NCT07199374Recruiting

PARCA (a Digital Tool) to Improve Justice and Health

The purpose of this study is to assess the effectiveness of the Probation/Parole and Reentry Coach Application (PARCA)-a mobile application that allows justice-involved people to set and manage person...

Dallas, PA50 participantsGeorge Mason University

View Study Details

NCT05239624Recruiting

Enfortumab Vedotin and Pembrolizumab in People with Bladder Cancer

This study will test whether enfortumab vedotin combined with pembrolizumab is an effective treatment for people with bladder cancer (urothelial carcinoma) involving the lymph nodes who are going to h...

Dallas, PA23 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06394570Recruiting

Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer

STAR-EV will evaluate the combination of enfortumab vedotin plus radiotherapy (RT) as neoadjuvant treatment for muscle invasive bladder cancer prior to radical cystectomy surgery. The study will use "...

Dallas, PA19 participantsUniversity of Texas Southwestern Medical Center

View Study Details

About ADHD Clinical Trials in Dallas

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning. It affects both children and adults. Treatment includes behavioral therapy, stimulant and non-stimulant medications, and educational support.

There are currently 14 adhd clinical trials recruiting participants in Dallas, PA. These studies are seeking a combined 6,753 participants. Research is being sponsored by M.D. Anderson Cancer Center, University of Texas Southwestern Medical Center, Cedars-Sinai Medical Center and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

ADHD Clinical Trials in Dallas — FAQ

Are there adhd clinical trials in Dallas?

Yes, there are 14 adhd clinical trials currently recruiting in Dallas, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Dallas?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you about next steps.

Are clinical trials in Dallas free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dallas studies also compensate for your time and travel.

What adhd treatments are being tested?

The 14 active trials in Dallas are testing new therapies including novel drugs, biologics, and treatment approaches for adhd.

Data updated July 13, 2026 from ClinicalTrials.gov